Mutation patterns for two flaviviruses: hepatitis C virus and GB virus C/hepatitis G virus

Related Experiment Video

Updated: Oct 20, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

M Mizokami1, T Imanishi, K Ikeo

  • 1Second Department of Medicine, Nagoya City University Medical School, Nagoya, Japan. mizokami@med.nagoya-cu.ac.jp

FEBS Letters
|June 8, 1999
PubMed

Insights

Hepatitis C virus (HCV) and GB virus C/hepatitis G virus (HGV) share similar mutation patterns with human genes, unlike HIV. This suggests potential side effects of antiviral drugs on human cells.

Area of Science:

  • Virology
  • Molecular Biology
  • Genetics

Background:

  • Hepatitis C virus (HCV) and GB virus C/hepatitis G virus (HGV) are significant human pathogens.
  • Understanding viral mutation patterns is crucial for developing effective antiviral therapies.
  • Human immunodeficiency virus (HIV) serves as a contrasting model for viral mutation analysis.

Purpose of the Study:

  • To compare the mutation patterns of HCV and HGV with each other and with HIV.
  • To investigate the similarity between viral mutation patterns and human nuclear pseudogenes.
  • To infer potential implications for antiviral drug development and safety.

Main Methods:

  • Comparative analysis of viral mutation patterns.
  • Statistical assessment of sequence similarity between viruses and human nuclear pseudogenes.
  • Analysis of mutation profiles of Hepatitis C virus (HCV), GB virus C/hepatitis G virus (HGV), and Human Immunodeficiency Virus (HIV).

Main Results:

  • HCV and HGV exhibited similar mutation patterns to each other.
  • HCV and HGV mutation patterns were significantly different from HIV.
  • A statistically significant similarity was observed between HCV/HGV and human nuclear pseudogenes, but not between HIV and human nuclear pseudogenes.

Conclusions:

  • The mutation patterns of HCV and HGV resemble spontaneous substitution mutations in human genes.
  • This similarity suggests that antiviral nucleotide analogues targeting HCV and HGV might affect normal human cells.
  • Further research is warranted to explore the safety and specificity of antiviral agents targeting these viruses.

More Related Videos

Hepatitis E Virus Fluorescence Reduction Neutralization Test for Measuring Neutralizing Antibody Titers07:58

Hepatitis E Virus Fluorescence Reduction Neutralization Test for Measuring Neutralizing Antibody Titers

Published on: May 22, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...